Yan Liang

4.1k citations
93 papers · 1.9k indexed · h-index 23
Topics
RNA modifications and cancer (9 papers)Cancer-related molecular mechanisms research (7 papers)CRISPR and Genetic Engineering (6 papers)

In The Last Decade

Yan Liang

85 papers receiving 1.9k citations

Peers

Yan Liang
Comparison fields: 5 of 128
  • Molecular Biology 1.1k
  • Cancer Research 690
  • Oncology 275
  • Biomedical Engineering 199
  • Immunology 170
Replace Masaki Miyazawa with:
Masaki Miyazawa Japan
Yugang Wang China
Lin Tang China
Lan Liu China
Xin Hu China
Liang Ming China
Arumugam Jayakumar United States
Xiaohua Zhu China
Sylwia Bartoszewska Poland
Yan Liang relative to Masaki Miyazawa Japan Masaki Miyazawa's profile →
Citations per field
00.5×2.9×
Masaki Miyazawa · 1×
Citations per year

Countries citing papers authored by Yan Liang

Since Specialization
Citations

This map shows the geographic impact of Yan Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Liang more than expected).

Fields of papers citing papers by Yan Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Liang. The network helps show where Yan Liang may publish in the future.

Co-authorship network of co-authors of Yan Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Liang. A scholar is included among the top collaborators of Yan Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Liang. Yan Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 5
5 5
6 0
7 3
8 5
9 14
10 27
11 30
12 117
13 17
14 33
15 31
16 1
17
Cloning, full-length sequence analysis and prokaryotic expression of astakine gene of Litopenaeus vannamei
2
18 27
19 12
20
Elevated extracellular calcium can prevent and promote apoptosis
1

About Yan Liang

Yan Liang is a scholar working on Cancer Research, Molecular Biology and Virology, having authored 93 papers that have together received 1.9k indexed citations. Recurring topics across this work include RNA modifications and cancer (9 papers), Cancer-related molecular mechanisms research (7 papers) and CRISPR and Genetic Engineering (6 papers). The work is most often cited by research in Cancer Research (690 citations), Molecular Biology (1.1k citations) and Oncology (275 citations). Yan Liang has collaborated with scholars based in China, United States and New Zealand. Frequent co-authors include Yun Bai, Xingying Guan, Xuedan Chen, Kang Yang, Kai Wang, Juan Li, Kaixiang Zhang, Sixuan Wu, Shi‐Xin Zhang and Yuanyuan Wu. Their work appears in journals such as Journal of the American Chemical Society, Advanced Materials and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026